Diastolic Heart Failure Clinical Trial
Official title:
Effects of the Dietary Approaches to Stop Hypertension(DASH) Sodium-restricted Diet on Ventriculovascular Function in Heart Failure With Preserved Systolic Function
Heart failure with preserved systolic function (HF-PSF, or 'diastolic heart failure')
accounts for half of hospitalizations for heart failure in patients over the age of 65. Most
HF-PSF patients have systemic hypertension (HTN), and characteristic HTN-induced
cardiovascular changes contribute to HF-PSF. However, it is unclear why most patients with
HTN never develop HF-PSF or which specific aspects of HTN predispose to HF-PSF.
In the Dahl S rat, the primary animal model of HF-PSF, high dietary sodium intake suppresses
the systemic renin-angiotensin-aldosterone system, but upregulates renal and cardiac
renin-angiotensin-aldosterone system by inducing oxidative stress. In humans, the magnitude
of blood pressure response to sodium ingestion and depletion can categorize subjects as
"salt-resistant" and "salt-sensitive." Human salt sensitivity is associated with structural
and loading conditions that increase the risk for HF-PSF, including HTN, ventricular
hypertrophy and diastolic dysfunction, arterial stiffening, and increased plasma volume. High
dietary sodium intake induces oxidative stress in salt-sensitive humans. In humans with HTN
and normal ventricular systolic function that do not have heart failure, increased oxidative
stress predicts impaired exercise capacity, ventricular hypertrophy, diastolic dysfunction,
arterial stiffening, and vascular endothelial dysfunction. The investigators have proposed
that "salt sensitivity" and the accompanying oxidative stress on the typical high-sodium
Western diet may contribute to the initiation and progression of HF-PSF.
In patients with HF-PSF, the investigators will relate dietary changes to biochemical and
cardiovascular functional measures. The investigators will study subjects on ad-lib diet and
and following three weeks of rigorous dietary modification with the Dietary Approaches to
Stop Hypertension (DASH)/sodium-restricted diet (SRD). This diet is richer in natural
antioxidants and lower in sodium than the usual American diet. The DASH/SRD is recommended to
lower blood pressure in patients with HTN, and is particularly effective in elderly, obese,
and salt-sensitive hypertensives. Dietary sodium restriction is recommended for all HF
patients including those with HF-PSF. The investigators hypothesize that the DASH/SRD will
have favorable effects on oxidative stress, ventricular and vascular function, and blood
pressure control in patients with hypertensive HF-PSF.
n/a
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT02499601 -
CORolla® TAA for Heart Failure With Preserved Ejection Fraction (HFpEF) and Diastolic Dysfunction (DD)
|
N/A | |
Completed |
NCT02537041 -
Non-invasive Evaluation of Myocardial Stiffness by Elastography
|
N/A | |
Completed |
NCT02275793 -
The Regulation of Pulmonary Vascular Resistance in Patients With Heart Failure
|
||
Withdrawn |
NCT00773084 -
Aliskiren and Renin Inhibition in Diastolic Heart Failure
|
N/A | |
Terminated |
NCT00293150 -
Reversing Endothelial and Diastolic Dysfunction and Improving Collagen Turnover in Diastolic Heart Failure
|
Phase 4 | |
Terminated |
NCT01942395 -
Dietary Approaches to Stop Hypertension in 'Diastolic' Heart Failure 2 (DASH-DHF 2)
|
N/A | |
Recruiting |
NCT03157219 -
Manipal Heart Failure Registry (MHFR)
|
N/A | |
Terminated |
NCT01778894 -
Mathematical Modeling to Determine Basic Muscle Properties in the Failing Heart
|
||
Completed |
NCT04154878 -
2 New Measurements Used to Describe the Filling Phase of the Left Ventricle (LV).
|
||
Recruiting |
NCT01599117 -
A Randomized Trial of Udenafil Therapy in Patients With Heart Failure With Preserved Ejection Fraction [ULTIMATE-HFpEF]
|
Phase 3 | |
Completed |
NCT01185067 -
Physiological Effects of Grape Seed Extract in Diastolic Heart Failure
|
Phase 1 | |
Completed |
NCT03338374 -
Cardiac Resynchronisation Therapy Versus Rate-responsive Pacing in Heart Failure With Preserved Ejection Fraction
|
N/A | |
Completed |
NCT02589977 -
Myocardial Perfusion, Oxidative Metabolism, and Fibrosis in HFpEF
|
Phase 4 | |
Completed |
NCT02147613 -
High Intensity Interval Exercise in Diastolic Heart Failure
|
N/A | |
Terminated |
NCT00083772 -
Use of Nesiritide in the Management of Acute Diastolic Heart Failure
|
Phase 4 | |
Completed |
NCT00303498 -
A Study of the Effectiveness of Sitaxsentan Sodium in Patients With Diastolic Heart Failure
|
Phase 2 | |
Terminated |
NCT02254382 -
Positive Airway Pressure Therapy Study in Sleep Apnea and Diastolic Heart Failure
|
N/A | |
Completed |
NCT00839228 -
Perhexiline Therapy in Heart Failure With Preserved Ejection Fraction Syndrome
|
Phase 2 | |
Terminated |
NCT00662116 -
Beginning a Randomized Evaluation of the AGE Breaker Alagebrium in Diastolic Heart Failure (BREAK-DHF-I)
|
Phase 2 | |
Completed |
NCT02084992 -
A Study of a Technology-enabled Disease Management Program to Reduce Hospitalizations for Heart Failure
|
N/A |